[Form 3] Synopsys Inc Initial Statement of Beneficial Ownership

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Vijayaraghavan Ravi K

Role Director

Type	Security	Shares	Price	Value
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,074 shares (Direct)

Footnotes (1)

1. F1. On July 17, 2025, Synopsys, Inc. (Synopsys) completed its merger with ANSYS, Inc. (Ansys), pursuant to the Agreement and Plan of Merger, dated January 15, 2024 (Merger Agreement), by and among Synopsys, Ansys and ALTA Acquisition Corp., a wholly owned subsidiary of Synopsys (Merger Sub). Pursuant to the Merger Agreement, Merger Sub was merged with and into Ansys (Merger), with Ansys surviving the Merger as a wholly owned subsidiary of Synopsys. At the effective time of the Merger (Effective Time), each share of common stock, par value $0.01 per share, of Ansys (Ansys Common Stock) issued and outstanding immediately prior to the Effective Time (subject to certain exceptions) was converted into the right to receive (i) 0.3399 of a share of common stock, par value $0.01 per share, of Synopsys (Synopsys Common Stock) (rounded down to the nearest whole share) and (ii) $199.91 in cash (plus cash in lieu of any fractional share of Synopsys Common Stock), without interest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/24/2025 - 07:01 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Vijayaraghavan Ravi K

(Last) (First) (Middle)

675 ALMANOR AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/17/2025

3. Issuer Name and Ticker or Trading Symbol
SYNOPSYS INC [ SNPS ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	2,074(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 17, 2025, Synopsys, Inc. (Synopsys) completed its merger with ANSYS, Inc. (Ansys), pursuant to the Agreement and Plan of Merger, dated January 15, 2024 (Merger Agreement), by and among Synopsys, Ansys and ALTA Acquisition Corp., a wholly owned subsidiary of Synopsys (Merger Sub). Pursuant to the Merger Agreement, Merger Sub was merged with and into Ansys (Merger), with Ansys surviving the Merger as a wholly owned subsidiary of Synopsys. At the effective time of the Merger (Effective Time), each share of common stock, par value $0.01 per share, of Ansys (Ansys Common Stock) issued and outstanding immediately prior to the Effective Time (subject to certain exceptions) was converted into the right to receive (i) 0.3399 of a share of common stock, par value $0.01 per share, of Synopsys (Synopsys Common Stock) (rounded down to the nearest whole share) and (ii) $199.91 in cash (plus cash in lieu of any fractional share of Synopsys Common Stock), without interest.

	By: POA pursuant Liz Ramirez For: Ravi Vijayaraghavan	07/24/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.